Surgical treatment for Parkinson's disease: Neural transplantation

Movement Disorders

Volumn 17, Issue SUPPL. 4, 2002, Pages

  Goetz, C G ^a   Koller, W C ^a   Poewe, W ^a   Rascol, O ^a   Sampaio, C ^a   Brin, M F ^a   Lees, Andrew J ^a   LeWitt, P ^a   Lozano, A ^a   Mizuno, Y ^a   Nutt, J ^a   Oertel, W ^a   Olanow, C W ^a   Tolosa, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ARTICLE; CELL TRANSPLANTATION; CLINICAL STUDY; CLINICAL TRIAL; DISEASE COURSE; DOPAMINERGIC NERVE CELL; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; MESENCEPHALIC CELL TRANSPLANTATION; MESENCEPHALON; META ANALYSIS; MOTOR DYSFUNCTION; NERVE TRANSPLANTATION; PARKINSON DISEASE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SYMPTOMATOLOGY;

BRAIN; FETAL TISSUE TRANSPLANTATION; HUMANS; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS; TISSUE TRANSPLANTATION;

EID: 0036920304     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.5575     Document Type: Article

References (42)

1. Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease. Neurology 1998;50(3 Suppl 3):S1-57.
2. Fahn S. Adverse effects of levodopa. In: Olanow CW, Lieberman AN, eds. The Scientific Basis for the Treatment of Parkinson's Disease. UK, Lancs: Arthenon Publishing Group, 1992: p. 89-112.
3. Olanow CW, Kordower JH, Freeman TB. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 1996;19:102-109.
4. Goetz CG, Olanow CW, Koller WC, et al. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinsons's disease. N Engl J Med 1989;320:337-341.
5. Olanow CW, Koller W, Goetz, et al. Autologous transplantation of adrenal medulla in Parkinson's disease: 18-month results. Arch Neurol 1990;47:1286-1289.
6. Itakura T, Kamei I, Nakai K, et al. Autotransplantation of the superior cervical ganglion into the brain. A possible therapy for Parkinson's disease. J Neurosurg 1988;68:955-959.
7. Itakura T, Uematsu Y, Nakao N, et al. Transplantation of autologous sympathetic ganglion into the brain with Parkinson's disease. Long-term follow-up of 35 cases. Sterotactic Funct Neurosurg 1997;69:112-115.
8. Wenning GK, Odin P, Morrish P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997;42:95-107.
9. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994;35:172-180.
10. Remy P, Samson Y, Hantrave P, et al. Clinical correlates of [18F]fluorodopa uptake in five grafted parkinonian patients. Ann Neurol 1995;38:580-588.
11. Freeman TB, Olanow CW, Hauser RA, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995;38(3):379-88.
12. Kordower JH, Freeman TB, Snow BJ, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995;332:1118-1124.
13. Kordower JH, Rosenstein JM, Collier TJ, et al. Functional fetal nigral grafts in a patient with Parkinson's disease; chemoanatomic, quantitative, ultrastructural, and metabolic studies. J Comp Neurol 1996;370:203-230.
14. Freeman TB, Vawter DE, Leaverton PE, et al. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med 1999;341:988-992.
15. Spencer DD, Robbins RJ, Naftolin F, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992;327(22):1541-1548.
16. Redmond DE Jr., Leranth C, Spencer DD, et al. Fetal neural graft survival. Lancet 1990;336:820-822.
17. Kopyov OV, Jacques DS, Lieberman A, Duma CM, Rogers RL. Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue. Exp Neurol 1997;146:536-545.
18. Freed CR, Greene PE, Breeze RE, Tsai WY, et al. Transplantation of embryonic dopamine neurons are severe Parkinson's disease. N Engl J Med 2001;344:710-719.
19. Nakamura T, Dhawan V, Chaly T, Kukuda M, et al. Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease. Ann Neurol 2001;50:181-187.
20. Lindvall O, Rechnerona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989;46:615-631.
21. Hoffer BJ, Leenders KL, Young D et al. Eighteen month course of two patients with grafts of fetal dopamine neurons for Parkinson's disease. Exp Neurol 1992;118:243-252.
22. Lindvall O, Widner H, Rehncrona S, et al. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 1992;31:155-165.
23. Lindvall O, Widner H, Rehncrona S, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990;247-574-577.
24. Sawle GV, Bloom field PM, Bjorklund A, et al. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in tow patients with putaminal implants. Ann Neurol 1992;31:166-173.
25. Defer GL, Geny C, Ricolfi F, et al. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 1996;119:41-50.
26. Peschanski M, Defer G, N'Guven JP, et al. Bilateral motor improvement and alternation of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994;117:487-499.
27. Hauser RA, Freeman TB, Snow BJ, et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson's disease. Arch Neurol 1999;56:179-187.
28. Kordower JH, Freeman TB, Chen EY, et al. Fetal nigral grafts survival and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 1998;13:383-393.
29. Freed CR, Breeze RE, Rosenberg NL, et al. Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. Arch Neurol 1990;47:505-512.
30. Freed CR, Breeze RE, Rosenberg NL, et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 1992;327(22):1549-1555.
31. Freed CR, Rosenberg NL, Schneck SA, Breeze RE. Improved drug responsiveness following fetal tissue implant for Parkinson's disease. Neurochem Int 1992;20(suppl):321S-327S.
32. Lopez-Lozano JJ, Bravo G, Brera B, et al. Long-term follow-up in 10 Parkinson's disease patients subjected to fetal brain grafting into a cavity in the caudate nucleus: the Clinica Puerta de Hierro experience. CPH Neural Transplantation Group. Transplant Proc 1995;27:1395-1400.
33. Lopez-Lozano JJ, Bravo G, Brera B, et al. Long-term improvement in patients with severe Parkinsons's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow-up in 10 patients. Clinica Puerta de Hierro Neural transplantation Group. J Neurosurg 1997;86:931-942.
34. Kopyov OV, Jacques D, Lieberman A, Duma CM, Rogers RL. Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell Transplant 1996;5:327-337.
35. Molina H, Quinones R, Ortega I, et al. Computer assisted CT-guided stereotactic transplantation of foetal ventral mesencephalon to the caudate nucleus and putamen in Parkinson's disease. Acta Neurochir Suppl (Wien) 1993:58;17-19.
36. Sass KJ, Buchanan CP, Westerveld M, et al. General cognitive ability following unilateral and bilateral fetal ventral mesencephalic tissue transplantation for treatment of Parkinson's disease. Arch Neurol 1995;52:680-686.
37. Price LH, Spencer DD, Marek KL et al. Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease. Biol Psychiatry 1995;38:498-505.
38. Cubo E, Gracies JM, Benabou R, Olanow CW, et al. Early morning off-medication dyskinesias, dystonia and choreic subtypes. Arch Neurol 2001;58:1379-1382.
39. Folkerth RD, Durso R. Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allogafts. Neurology 1996;46:1219-1225.
40. Kordower JH, Freeman TB, Bakay RA, Goetz CG, Olanow CW. Treatment with fetal allografts. Neurology 1997;48:1737-1738.
41. Schumacher JM, Ellias SA, Palmer EP, et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 2000;54:1042-1050.
42. Deacon T, Schumacher J, Dinsmore J, et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997;3:350-353.